CXCL10 and metabolic dysfunction-associated steatotic liver disease: Accordingly, IP-10 levels were increased in the early stage of type 1 diabetes (61) and were also predictive of insulin resistance and diabetes in patients suffering from nonalcoholic fatty liver disease (62).